Anzeige
Mehr »
Login
Freitag, 19.04.2024 Börsentäglich über 12.000 News von 689 internationalen Medien
Goldaktie: Eine Erfolgsgeschichte, die seinesgleichen sucht, startet gerade richtig durch!
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche
PR Newswire
222 Leser
Artikel bewerten:
(0)

Law Firm of Levi & Korsinsky, LLP Announces Class Action Against DGSE Companies Inc. (DGSE), Body Central Corp. (BODY) and Vertex Pharmaceuticals Inc. (VRTX) and Investigation of Mediware Information Systems, Inc. (MEDW)

NEW YORK, Sept. 24, 2012 /PRNewswire/ --

DGSE Companies Inc.
Levi & Korsinsky announces that a class action lawsuit has been commenced in the USDC for the Northern District of Texas on behalf of investors who purchased DGSE Companies Inc. (NYSE MKT: DGSE) stock between April 15, 2011 and April 17, 2012.

For more information, click here: http://zlk.9nl.com/dgse-companies-dgse. You have until November 6, 2012 to request that the Court appoint you as lead plaintiff.

Body Central Corporation
Levi & Korsinsky announces that a class action lawsuit has been commenced in the S District Court for the Middle District of Florida on behalf of investors who purchased Body Central Corporation (NasdaqGS: BODY) securities between November 10, 2011 and June 18, 2012.

For more information, click here: http://zlk.9nl.com/body-central-body. You have until October 29, 2012 to request that the Court appoint you as lead plaintiff.

Vertex Pharmaceuticals Incorporated
Levi & Korsinsky announces that a class action lawsuit has been commenced in the United States District Court for the District of Massachusetts on behalf of investors who acquired Vertex Pharmaceuticals Incorporated (NasdaqGS: VRTX) securities between May 7, 2012 and June 27, 2012.

For more information, click here: http://zlk.9nl.com/vertex-pharmaceuticals-vertex. You have until November 5, 2012 to request that the Court appoint you as lead plaintiff.

Mediware Information Systems, Inc.
Levi & Korsinsky is investigating the Board of Directors of Mediware Information Systems, Inc. (Nasdaq: MEDW) for possible breaches of fiduciary duty and other violations of state law in connection with the sale of the Company to Thoma Bravo, LLC. for $22.00 per share.

Click here to learn more about the investigation: http://zlk.9nl.com/mediware-information-systems-medw, or call: 877-363-5972.

Levi & Korsinsky is a national firm with offices in New York and Washington D.C. The firm has extensive expertise in prosecuting securities litigation involving financial fraud, representing investors throughout the nation in securities and shareholder lawsuits. Attorney advertising. Prior results do not guarantee similar outcomes.

CONTACT:
Levi & Korsinsky, LLP
Joseph Levi, Esq.
30 Broad Street - 24th Floor
New York, NY 10004
Tel: (212) 363-7500
Toll Free: (877) 363-5972
Fax: (212) 363-7171
www.zlk.com

SOURCE Levi & Korsinsky, LLP

Großer Insider-Report 2024 von Dr. Dennis Riedl
Wenn Insider handeln, sollten Sie aufmerksam werden. In diesem kostenlosen Report erfahren Sie, welche Aktien Sie im Moment im Blick behalten und von welchen Sie lieber die Finger lassen sollten.
Hier klicken
© 2012 PR Newswire
Werbehinweise: Die Billigung des Basisprospekts durch die BaFin ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.